
Carlsmed Inc (CARL) Stock Forecast & Price Target
Carlsmed Inc (CARL) Analyst Ratings
Bulls say
Carlsmed is a promising investment with a strong competitive advantage in the personalized spine implant market. Its innovative, AI-enabled technology has shown promising clinical data and low revision rates, attracting a growing number of surgeries. The company's expanding product offerings, strong patent portfolio, and experienced management team all point towards potential for high revenue growth and profitability in the future. Despite competition in the market, Carlsmed's unique offerings and successful results make it a strong buy for investors.
Bears say
Carlsmed is currently facing a challenging competitive landscape with a crowded market for spine surgery solutions. Additionally, the company's current low-priced products and limited product portfolio may make it difficult to increase profitability in the near future. Furthermore, the company's high valuation, at a 2026 EV/sales multiple of 2.7x, is significantly higher than its small/mid-cap orthopedics and spine group's median multiple of 1.8x, indicating significant downside potential.
This aggregate rating is based on analysts' research of Carlsmed Inc and is not a guaranteed prediction by Public.com or investment advice.
Carlsmed Inc (CARL) Analyst Forecast & Price Prediction
Start investing in Carlsmed Inc (CARL)
Order type
Buy in
Order amount
Est. shares
0 shares